ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,155Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 134

$878K Total Retail Price of All Prescriptions

Rank: 5 out of 134

492 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Idaho
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 492 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 492 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 12,102 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Idaho
LEVOTHYROXINE SODIUM 709 665 1 1
LISINOPRIL 505 476 2 4
AMLODIPINE BESYLATE 404 363 3 6
SIMVASTATIN 389 369 4 2
OMEPRAZOLE 339 283 5 3
FUROSEMIDE 292 285 6 7
HYDROCODONE-ACETAMINOPHEN 286 275 S3 7 5
WARFARIN SODIUM 276 266 8 8
CITALOPRAM HBR 264 250 9 14
LOSARTAN POTASSIUM 261 250 10 11
HYDROCHLOROTHIAZIDE 243 205 11 13
METFORMIN HCL ER 241 216 12 43
GABAPENTIN 233 192 13 12
METFORMIN HCL 222 205 14 9
METOPROLOL SUCCINATE 214 205 15 16
POTASSIUM CHLORIDE 207 176 16 10
LANTUS 187 162 17 32
ATORVASTATIN CALCIUM 186 180 18 18
GLIMEPIRIDE 170 148 19 36
PRAVASTATIN SODIUM 169 162 20 20
METOPROLOL TARTRATE 151 138 21 17
CARVEDILOL 146 146 22 27
FENOFIBRATE 144 142 23 79
LISINOPRIL-HYDROCHLOROTHIAZIDE 134 125 24 45
NOVOLOG 126 125 25 72
ZOLPIDEM TARTRATE 122 105 26 15
DIOVAN 119 119 27 55
CRESTOR 116 102 28 39
ALENDRONATE SODIUM 102 87 29 21
LOSARTAN-HYDROCHLOROTHIAZIDE 98 98 30 50
LOVASTATIN 97 97 31 33
MELOXICAM 95 94 32 35
GEMFIBROZIL 94 90 33 87
CLOPIDOGREL 94 94 33 52
ALLOPURINOL 90 90 35 25
AMLODIPINE BESYLATE-BENAZEPRIL 88 86 36 113
ADVAIR DISKUS 87 87 37 38
TRAMADOL HCL 87 61 37 22
NOVOLOG FLEXPEN 86 71 39 109
SERTRALINE HCL 84 76 40 24
LANTUS SOLOSTAR 83 79 41 62
TAMSULOSIN HCL 82 82 42 26
BUPROPION XL 82 59 42 108
PLAVIX 79 79 44 86
BENICAR 79 79 44 129
ZETIA 74 72 46 95
DOXAZOSIN MESYLATE 71 71 47 68
PAROXETINE HCL 70 69 48 46
JANUVIA 69 68 49 77
BUMETANIDE 69 69 49 147
INSULIN SYRINGE 68 62 51 104
LIDODERM 66 55 52 207
ROPINIROLE HCL 65 54 53 63
ESTRADIOL 64 53 R 54 66
FLUOXETINE HCL 63 52 55 42
DIGOXIN 63 51 55 31
PEN NEEDLE 60 51 57 90
SPIRIVA 59 57 58 47
ATENOLOL 55 50 59 19
FENTANYL 55 44 S2 59 41
SYNTHROID 54 54 61 56
PROAIR HFA 53 51 62 49
NEXIUM 52 47 63 54
VENLAFAXINE HCL ER 51 37 64 61
PANTOPRAZOLE SODIUM 50 50 65 57
DONEPEZIL HCL 50 50 65 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 18, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.